Eton Pharmaceuticals dismisses auditor Crowe, appoints Grant Thornton

Eton Pharmaceuticals, Inc.

Effective June 13, 2025, Eton dismissed Crowe LLP as its independent auditor.
No disagreements or reportable events occurred during Crowe's tenure (fiscal year 2024).
Audit Committee appointed Grant Thornton LLP as new auditor for fiscal year 2025.
Crowe's audit report for FY 2024 was unqualified; no adverse opinions or modifications.
Company provided Crowe with disclosures; Crowe's letter filed as Exhibit 16.1.

item 4.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.